The role of planned angiographic control (PAC) over a conservative management driven by symptoms and ischaemia following percutaneous coronary intervention (PCI) of the unprotected left main (ULM) with second-generation drug-eluting stents remains controversial. PAC may timely detect intrastent restenosis, but it is still unclear if this translated into improved prognosis.
Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trial
De Filippo, OvidioFirst
;Iannaccone, Mario;Gaido, Luca;Zaccaro, Lorenzo;Depaoli, Alessandro;Quadri, Giorgio;Gagnor, Andrea;Boccuzzi, Giacomo;Solitro, Federica;Guarnaccia, Carla;Tore, Davide;Veltri, Andrea;Franchin, Luca;Angelini, Filippo;Marchisio, Filippo;Fonio, Paolo;De Ferrari, Gaetano Maria;Cerrato, Enrico;D'Ascenzo, FabrizioLast
2020-01-01
Abstract
The role of planned angiographic control (PAC) over a conservative management driven by symptoms and ischaemia following percutaneous coronary intervention (PCI) of the unprotected left main (ULM) with second-generation drug-eluting stents remains controversial. PAC may timely detect intrastent restenosis, but it is still unclear if this translated into improved prognosis.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
manuscript.pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
722.41 kB
Formato
Adobe PDF
|
722.41 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
